Your browser doesn't support javascript.
loading
Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy.
De, Brian; Ng, Sweet Ping; Liu, Amy Y; Avila, Santiago; Tao, Randa; Holliday, Emma B; Brownlee, Zachary; Kaseb, Ahmed; Lee, Sunyoung; Raghav, Kanwal; Vauthey, Jean-Nicolas; Minsky, Bruce D; Herman, Joseph M; Das, Prajnan; Smith, Grace L; Taniguchi, Cullen M; Krishnan, Sunil; Crane, Christopher H; Grassberger, Clemens; Hong, Theodore S; Lin, Steven H; Koong, Albert C; Mohan, Radhe; Koay, Eugene J.
Affiliation
  • De B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Liu AY; Department of Radiation Oncology, Austin Health, Melbourne, Victoria, Australia.
  • Avila S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tao R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Holliday EB; Department of Radiation Oncology, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Brownlee Z; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kaseb A; Department of Radiation Oncology, Tufts Medical Center, Boston, MA, USA.
  • Lee S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Raghav K; Department of Radiation Oncology, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Vauthey JN; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Minsky BD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Herman JM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Das P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Smith GL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Taniguchi CM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Krishnan S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Crane CH; Department of Radiation Oncology, Mayo Clinic Jacksonville, Jacksonville, FL, USA.
  • Grassberger C; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hong TS; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Lin SH; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Koong AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mohan R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Koay EJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
J Hepatocell Carcinoma ; 8: 57-69, 2021.
Article in En | MEDLINE | ID: mdl-33688489

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Hepatocell Carcinoma Year: 2021 Document type: Article Affiliation country: United States Country of publication: New Zealand

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Hepatocell Carcinoma Year: 2021 Document type: Article Affiliation country: United States Country of publication: New Zealand